Parkinsonism with excessive daytime sleepiness - A narcolepsy-like disorder?

被引:81
作者
Baumann, C
Ferini-Strambi, L
Waldvogel, D
Werth, E
Bassetti, CL
机构
[1] Univ Spital Zurich, Neurol Poliklin, CH-8091 Zurich, Switzerland
[2] Univ Vita Salute San Raffaele, Sleep Disorders Ctr, Milan, Italy
关键词
Parkinsonism; narcolepsy; REM sleep behavior disorder; hypocretin; excessive daytime sleepiness; Epworth sleepiness score; sleep attacks;
D O I
10.1007/s00415-005-0614-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Parkinsonian patients with excessive daytime sleepiness (EDS), hallucinations, REM sleep behavior disorder (RBD), short mean sleep latencies, and sleep-onset REM periods (SOREMP) on multiple sleep latency tests (MSLT) have been reported. In these patients a narcolepsy-like pathophysiology of sleep-wake disturbances has been suggested. Patients and methods We studied 14 consecutive patients with Parkinsonism and EDS. Standard studies included assessment of duration and severity of Parkinsonism (Hoehn & Yahr score), Epworth sleepiness score (ESS), history of "REM-symptoms" (RBD/hallucinations/sleep paralysis/ cataplexy-like episodes), polysomnography (PSG), MSLT, and measurement of cerebrospinal fluid (CSF) levels of hypocretin-1 ( orexin A). Results There were 12 men and 2 women ( mean age 69 years; range 54 - 82). The mean duration and the Hoehn&Yahr score were 6.3 years and 2.2, respectively. Diagnoses included idiopathic Parkinson's disease (IPD, n= 10), dementia with diffuse Lewy bodies ( n= 3), and multisystem atrophy ( n= 1). The ESS was = 10 in all patients ( mean 12; range 10 - 18). "REM-symptoms" were reported by all but two patients ( hallucinations: n= 9; RBD: n= 9). None of the patients reported cataplexy-like symptoms or sleep paralysis. On PSG sleep apnea ( apnea hypopnea index > 10/h, n= 7), periodic limb movements during sleep (PLMS-index > 10/h, n= 6), and features of RBD ( n= 5) were found. On MSLT mean sleep latency was < 5 minutes in 10 patients, and SOREMP were found in two patients. When compared with controls ( n= 20, mean 497 pg/ml; range 350 - 603), CSF hypocretin-1 levels were normal in 8 patients and low in 2 patients ( 221 and 307 pg/ml, respectively). Conclusion These findings do not support the hypothesis of a "final common pathway" in the pathophysiology of narcolepsy and Parkinsonism with EDS. Sleep apnea and PLMS may play a so-far underestimated role in the pathogenesis of EDS in Parkinsonian patients.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 38 条
[21]   Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop [J].
McKeith, IG ;
Galasko, D ;
Kosaka, K ;
Perry, EK ;
Dickson, DW ;
Hansen, LA ;
Salmon, DP ;
Lowe, J ;
MIrra, SS ;
Byrne, EJ ;
Lennox, G ;
Quinn, NP ;
Edwardson, JA ;
Ince, PG ;
Bergeron, C ;
Burns, A ;
Miller, BL ;
Lovestone, S ;
Collerton, D ;
Jansen, ENH ;
Ballard, C ;
deVos, RAI ;
Wilcock, GK ;
Jellinger, KA ;
Perry, RH .
NEUROLOGY, 1996, 47 (05) :1113-1124
[22]   The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias [J].
Mignot, E ;
Lammers, GJ ;
Ripley, B ;
Okun, M ;
Nevsimalova, S ;
Overeem, S ;
Vankova, J ;
Black, J ;
Harsh, J ;
Bassetti, C ;
Schrader, H ;
Nishino, S .
ARCHIVES OF NEUROLOGY, 2002, 59 (10) :1553-1562
[23]   Daytime sleepiness and other sleep disorders in Parkinson's disease [J].
Ondo, WG ;
Vuong, KD ;
Khan, H ;
Atassi, F ;
Kwak, C ;
Jankovic, J .
NEUROLOGY, 2001, 57 (08) :1392-1396
[24]   Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness [J].
Overeem, S ;
van Hilten, JJ ;
Ripley, B ;
Mignot, E ;
Nishino, S ;
Lammers, GJ .
NEUROLOGY, 2002, 58 (03) :498-499
[25]   Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease [J].
Paus, S ;
Brecht, HM ;
Köster, J ;
Seeger, G ;
Klockgether, T ;
Wüllner, U .
MOVEMENT DISORDERS, 2003, 18 (06) :659-667
[26]   Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (Ergot) vs newer (Nonergot) dopamine agonists [J].
Razmy, A ;
Lang, AE ;
Shapiro, CM .
ARCHIVES OF NEUROLOGY, 2004, 61 (01) :97-102
[27]  
Rechtschaffen A., 1968, BRAIN INFORM SERVICE
[28]   CSF hypocretin/orexin levels in narcolepsy and other neurological conditions [J].
Ripley, B ;
Overeem, S ;
Fujiki, N ;
Nevsimalova, S ;
Uchino, M ;
Yesavage, J ;
Di Monte, D ;
Dohi, K ;
Melberg, A ;
Lammers, GJ ;
Nishida, Y ;
Roelandse, FWC ;
Hungs, M ;
Mignot, E ;
Nishino, S .
NEUROLOGY, 2001, 57 (12) :2253-2258
[29]   Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists [J].
Roth, T ;
Rye, DB ;
Borchert, LD ;
Bartlett, C ;
Bliwise, DL ;
Cantor, C ;
Gorell, JM ;
Hubble, JP ;
Musch, B ;
Olanow, CW ;
Pollak, C ;
Stern, MB ;
Watts, RL .
SLEEP MEDICINE, 2003, 4 (04) :275-280
[30]   Daytime sleepiness in Parkinson's disease [J].
Rye, DB ;
Bliwise, DL ;
Dihenia, B ;
Gurecki, P .
JOURNAL OF SLEEP RESEARCH, 2000, 9 (01) :63-69